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Synthetic biology, the science of engineering complex biological systems with novel functions, is increas-
ingly fascinating researchers across disciplines who gather to design functional biological assemblies in
a rational and systematic manner. Although initial success stories were based on reprogramming prokaryotic
and lower eukaryotic cells, the design of syntheticmammalian gene circuits is becoming increasingly popular
because it promises to foster novel therapeutic opportunities in the not-so-distant future. Here, we discuss
the latest generation of mammalian synthetic biology devices assembled to form complex synthetic gene
networks, such as regulatory cascades, logic evaluators, hysteretic circuits, epigenetic toggle switches,
time-keeping components, drug discovery tools, and ‘‘cell phone’’ units. We further highlight how such
circuits could be interconnected to achieve higher-order control networks such as synthetic hormone-like
communication systems in animals or synthetic ecosystems with dynamic interspecies crosstalk.Chemistry & Bidelayed expression kinetics (Weber et al., 2007c) and allowing
the engineering of synthetic hormone systems in mice as well
as the assembly of entire ecosystems with synthetic intra- and
interspecies crosstalk (Weber et al., 2007a). Because pioneering
strategies to engineer synthetic networks in bacteria and yeast
(see references above) are covered elsewhere, we focus on
the latest developments in the design of complex mammalian
gene networks and discuss future directions of mammalian
synthetic biology.
Mammalian Cell-Compatible Biological Parts
As Building Blocks For Construction
Of Synthetic Gene Networks
A consortium of experts from the Lawrence Berkeley National
Laboratory, MIT, and Harvard University have suggested to
define synthetic biology as ‘‘the design and construction of
new biological parts, devices, and systems and the redesign of
existing, natural biological systems for useful purposes’’
(http://syntheticbiology.org). This definition and the approach
to construct complex systems in living cells were inspired by
information technology and electronic engineering, where
complex assemblies like computer networks or the internet are
constructed by interconnecting basic modular parts such as
transistors, capacitors, or resistors. To transfer this design
principle—the construction of higher-order systems by assem-
bling modular parts—to biology, synthetic biologists prefer to
use standardized biological parts with well-defined and charac-
terized properties that can be connected to each other in
a predictable manner. Next, we provide an overview of today’s
most prominent mammalian cell-compatible biological parts:
synthetic DNA-binding receptors and transcription factors,
chemically induced dimerizing proteins, and signal-producing
enzymes. Recently developed RNA-based switches are
highlighted elsewhere and in this issue (Win and Smolke, 2008;
Win et al., 2009).
Synthetic DNA-Binding Receptors
and Transcription Factors
SyntheticDNA-binding receptors and transcription factors repre-
sent the most prominent family of mammalian cell-compatibleIntroduction
Complementary to classic (systems) biology where scientists
take biological systems apart to describe or gain insight into
functionalities of living systems, synthetic biology takes advan-
tage of rational reassembly of well-characterized biological parts
and devices into functional systems with novel or improved
characteristics. In recent years, systems biology has provided
an impressive wealth of details on the operation dynamics of
complex biological systems that had largely been elusive during
the genomics era. Because prokaryotes and lower eukaryotes
are more accessible to rational and precise genetic engineering,
pioneering advances in synthetic biology have mainly been
achieved in Escherichia coli and the yeast Saccharomyces cere-
visiae (Benner and Sismour, 2005; Drubin et al., 2007; Sprinzak
and Elowitz, 2005). Nonlimiting highlights include the first
synthetic bistable toggle switch (Gardner et al., 2000), self-
oscillating genetic networks (Elowitz and Leibler, 2000), artificial
cell-to-cell communication systems for the construction of
pattern-forming band-detection filters (Basu et al., 2005),
E. coli-based synthetic ecosystems (Balagadde et al., 2008),
and the design of complex translation-control networks (Isaacs
et al., 2004; Win and Smolke, 2008). Synthetic biology is also
beginning to impact translational research as exemplified by
engineering of bacteria for improved lycopene production (Alper
et al., 2005) or the synthesis of artemisin, the precursor of the
antimalaria drug Coartem (Martin et al., 2003).
Recent advances in heterologous mammalian transcription
control technology enabling precise adjustable and reversible
gene expression (Weber and Fussenegger, 2006, 2007a) have
prompted synthetic biology initiatives in mammalian cells and
entire animals (Deans et al., 2007; Greber and Fussenegger,
2007a; Kramer and Fussenegger, 2005; Kramer et al., 2004b;
Weber et al., 2007a, 2007c). After functional design of synthetic
replicas of natural network topologies (Weber and Fussenegger,
2002) such as regulatory cascades (Kramer et al., 2005, 2004b),
epigenetic toggle switches (Kramer et al., 2004b), and hysteretic
networks (Kramer and Fussenegger, 2005; May et al., 2008),
basic transcription control devices have been assembled and
interconnected to achieve higher-order control showing time-ology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 287
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gene networks. TheDNAbinding of these chimeric receptors and
transcription factors can be modulated by small-molecule
compounds or physical conditions and, depending on their
allostery, they bind to or are released from their operator in
response to the trigger (Weber and Fussenegger, 2007b).
Synthetic DNA-binding receptors and transcription factors are
typically engineered to modulate the activity of specific target
promoters by three distinct mechanisms (Weber and Fusseneg-
ger, 2006). (i) DNA-binding proteins which adjustably repress
promoters by binding to 30-placed operator modules. (ii)
Synthetic DNA-binding proteins fused to a transsilencing domain
(krueppel-associated box protein [KRAB] of human kox1) that
fine-tune expression of constitutive promoters when bound to
operators placed in their vicinity. (iii) Chimeric DNA-binding
proteins linked to transcription-activation domains (e.g., herpes
simplex virus protein 16 [VP16]) modulate transcription by
binding to cognate operators placed 50 of minimal eukaryotic
promoters (e.g., PhCMVmin). An impressive repertoire of such
synthetic mammalian transcription factors has been designed
and validated in mammalian cells and in mice and was shown
to be adjustable to a variety of compounds like antibiotics, Strep-
tomyces-derived quorum-sensing signals, metabolites, physical
conditions, amino acids, vitamins, or food additives (see Weber
and Fussenegger, 2007b for a comprehensive overview on
transcriptional repressors). Owing to their generic design,
synthetic transcription control systems are compatible and can
be simultaneously operated in mammalian cells for independent
or interconnected control of different (trans)genes (Fux et al.,
2004; Weber et al., 2002a). Also, all transcription-control modal-
ities can be optimized for expression performance and regulation
window using similar modification principles. (i) The synthetic
transcription factor can be expressed using different constitutive
(tissue-specific) promoters (Dickins et al., 2007). (ii) The DNA-
binding proteins can be fused to various transsilencing or trans-
activation domains optionally using linker peptides and/or
nuclear localization signals (Fussenegger et al., 2000; Weber
et al., 2002b). (iii) Different constitutive or minimal promoters
could be used to drive target gene expression (Weber et al.,
2002b). (iv) Operators can be multimerized to tandem units and
placed at different distances from constitutive or minimal
promoters (Gossen and Bujard, 1992; Weber et al., 2002b). (v)
When flanking inducible expression cassettes with insulator
sequences, transgene regulation canbe shielded fromdisturbing
transcriptional influence originating from neighboring chromo-
somal sequences (Pluta et al., 2005). (iv) The DNA-binding
proteins can be mutagenized to optimize induction characteris-
tics (Urlinger et al., 2000) or reverse the DNA-binding character-
istics in the presence of a specific inducer (Gossen et al., 1995).
The tuning flexibility andcompatibility amongeachother have es-
tablished DNA-binding transcription factors as the most impor-
tant class of proteins in the construction of synthetic gene
networks.
Chemically Induced Dimerizing Proteins
Chemically induced dimerization of engineered proteins has
been successfully used for trigger-adjustable induction of
membrane-bound receptor activity (Farrar et al., 1996), tran-
scription (Rivera et al., 1996; Zhao et al., 2003), translation
(Schlatter et al., 2003), secretion (Rivera et al., 2000), or enzyme288 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Allactivity (Rossi et al., 1997). In contrast to DNA-binding transcrip-
tion factors, for which highly diverse classes of inducer
substances exist, chemically induced dimerization is currently
limited to the use of rapamycin-induced dimerization of FK-
binding protein (FKBP) with FRB (Rivera et al., 1996), FK506-
dependent dissociation of FM-FM homodimers (Rivera et al.,
2000), dimerization of two FKBP proteins by dimeric FK506
(FK1012, Ho et al., 1996), dimerization of FKBP with cyclophilin
C by fusion of FK506 to cyclosporin A (Belshaw et al., 1996),
and the aminocoumarin antibiotic-triggered homodimerization
of two bacterial gyrase subunits (GyrB, Zhao et al., 2003).
Signal-Producing Enzymes
Signal-producing enzymes can either be used to trigger
assembly of different proteins or to produce messenger/inducer
substances that activate transgene expression in target cells.
Enzyme-triggered assembly of two proteins can be achieved
by taking advantage of the E. coli biotin ligase BirA. BirA
catalyzes biotinylation of proteins containing a specific avitag
motif that can then heterodimerize with another protein fused
to streptavidin. For example, fusion of avitag to a DNA-binding
domain and streptavidin to a transactivation domain enables
biotin-inducible BirA-mediated reconstitution of a synthetic
transactivator that can activate specific target promoters (Weber
et al., 2007c).
Examples for enzyme-generated messenger or inducer
compounds include biotinidase, which liberates biotin from
biocytin in order to trigger biotin-responsive expression systems
(Weber et al., 2007a), or alcohol dehydrogenase, which converts
ethanol to acetaldehyde and so activates acetaldehyde-
inducible transcription modalities (Weber et al., 2007a).
Synthetic Gene Networks in Mammalian Cells
Heterologous transgene regulation systems described above
are minimal control devices that can be used to fine-tune tran-
scription of specific target genes in a dose-dependent manner.
They can also be interconnected to provide higher-order regula-
tory gene networks that enable complex signal processing,
optimized regulation performance, and unprecedented control
features inaccessible to simple control devices (Greber and
Fussenegger, 2007a). Following, we discuss several examples
on how individual transgene control devices could be assembled
into more complex gene networks with novel regulation charac-
teristics.
Synthetic and Semisynthetic Regulatory Cascades
A prominent example of a synthetic mammalian gene network
consisted of an artificial two-step signaling cascade in which
a small-molecule-responsive transcription factor controlled
expression of a second transcription factor that then modulated
transcription of the target gene (Kramer et al., 2003). This daisy-
chain interconnection of individual transcription control circuits
was then successfully used to design a three-level transcription
cascade that provides discrete multilevel control in response to
different input signals (Kramer et al., 2003). This synthetic
mammalian three-step cascade consisted of the TET-responsive
promoter PTET driving dicistronic expression of TET-dependent
transactivator (tTA) and erythromycin-dependent transactivator
(ET1), whereby tTA was auto-activating PTET in a positive feed-
back loop together with cocistronically encoded ET1. ET1 was
programmed to activate the erythromycin (EM)-responsiverights reserved
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min-dependent transactivator, a PIP-VP16 fusion protein (PIT).
PIT was then activating its cognate promoter PPIR, thereby
controlling expression of human placental secreted alkaline
phosphatase (SEAP) (Figure 1A). The signaling cascade could
be interrupted at any level by the addition of TET, EM, or pristina-
mycin I, specifically inactivating tTA, ET1, and PIT, respectively.
Becauseeachantibiotic represses thecascadeat adifferent level
in the cascade, the impact of the transcription leakiness on the
overall transgene expression level varies depending at which
point in the cascade it occurs: expression levels of 100% (no
cascade intervention), 66% (intervention at first level of cascade),
33% (intervention at second level), and close to 0% (intervention
at third and final level) of transgene were possible (Figure 1A). In
this way a precise expression level could be achieved by addition
of aparticular antibiotic that enablesmolecule-specific titrationof
target genes (Kramer et al., 2003).
Capitalizing on the success of the synthetic three-level
cascade providing four discrete expression levels in response
to three different antibiotics, Kramer and coworkers have also
designed a semisynthetic cascade that could process endoge-
nous (e.g., hypoxia) and exogenous (e.g., an antibiotic) signals
to provide up to six discrete expression levels defined by the
combination of input signals (Figure 1B) (Kramer et al., 2005).
The endogenous hypoxia signal was plugged into the cascade
via hypoxia-responsive element fused to PSV40min. Under
hypoxia, the endogenous hypoxia-inducible factor (HIF)-1a
translocates into the nucleus, heterodimerizes with HIF-1b
and binds to hypoxia-responsive elements, thereby inducing
PSV40min. At normal oxygen levels (normoxia), hypoxia-inducible
factor (HIF)-1a is targeted for proteosomal destruction via its
oxygen-dependent degradation domain. The endogenous
hypoxia-inducible sensor system was linked to expression of
PIT, which was set to control PPIR-driven tTA expression and
tTA was arranged to drive PTET-controlled expression of SAMY
(Figure 1B). Using different combinations of endogenous
(hypoxia) or exogenous (addition of antibiotics) stimuli, SAMY
production could be adjusted to six discrete expression levels
(Kramer et al., 2005). Semisynthetic cascades provide a first
example how synthetic gene networks could be functionally
coupled to endogenous control circuits and yet retain respon-
siveness to external intervention factors.
Coupled Transcription-Translation Networks
Because the flow of genetic information from DNA to protein
involves transcription and translation, transgene expression
could be adjusted at both levels to enable protein production
fine-tuning with unmatched precision and tightness. Although
individual transcription (Gossen et al., 1995, see above) and
translation (Schlatter et al., 2003) units were successfully used
for trigger-inducible heterologous protein production inmamma-
lian cells, their regulation windows (the difference in protein
levels reached under fully induced or repressed conditions)
seemed to be a system-specific constant: maximum protein
production under induced conditions were typically associated
with significant leakiness in the repressed state and completely
tight control systems only reached mediocre maximum produc-
tion levels. Coupled transcription-translation networks that
suppress leaky transcripts could therefore expand the regulation
window and improve overall regulation performance.Chemistry & BioIn the first coupled transcription-translation network, tetracy-
cline (TETOFF-)-repressible expression of SEAP was functionally
linked to EM-inducible expression of a small interfering RNA
(siRNAGFP) specific for a GFP-derived sequence tag (TAGGFP)
engineered into the 50 untranslated region of SEAP (Figure 1C,
Malphettes and Fussenegger, 2006). Although SEAP production
was primarily responsive to TET showing typical TETOFF expres-
sion profiles, EM-induced kickoff of siRNAGFP transcription
during TET-mediated SEAP repression reduced leaky SEAP
transcript levels and improved the overall regulation perfor-
mance of the TETOFF system. The use of siRNA-specific
sequence tags unrelated to the target gene enables generic
target gene-independent translation control and provides
maximum flexibility for use in any coupled transcription-transla-
tion network.
In a similar approach, Jim Collins and coworkers (Deans et al.,
2007) used the isopropyl-b-D-thiogalactopyranoside (IPTG)-
inducible Lac switch system to coregulate expression of
tetracycline-dependent receptor (TetR) and the gene of interest
(GOI) by conditional IPTG-modulated binding LacI to its cognate
operator (lacO) placed between the constitutive promoter and
TetR or GOI, respectively (Figure 1D). GOI was engineered
to contain a sequence tag in the 30 untranslated region that
was specific for a short hairpin RNA (shRNA) transcribed in a
TET-specific operator-repressible TET-responsivemanner using
a TET-specific operator-linked PU6 promoter (Figure 1D). In the
absence of IPTG, LacI represses transcription of TetR and
GOI, which results in derepression of the TET-specific oper-
ator-linked PU6 promoter and consequent maximum shRNA
expression leading to RNA-interference-based elimination of
TAGed GOI and remarkable repression of GOI to over 99%.
In order to facilitate the design of such coupled transcription-
translation networks, a recent study (Greber and Fussenegger,
2007b) described an efficient strategy for the simultaneous
expression of synthetic transcription factors (see above)
harboring intronically encodedGOI-specific shRNAs. The poten-
tial of this integrated concept was exemplified by the simulta-
neous expression and knockdown of six genes controlled by
a single promoter (Greber and Fussenegger, 2007b). Also,
intronic siRNA-based translation control has recently been
shown to improve the dynamic range of epigenetic toggle
switches (see below; Greber et al., 2008).
Hysteretic Gene Switches
In contrast to the above-described inducible systemswith excel-
lent possibilities for adjustment and reversible on/off regulation,
many naturally occurring gene switches tend to behave hyster-
etically (Ozbudak et al., 2004). Classic genetic switches provide
a dose-dependent graded expression profile in response to the
inducer; however, in hysteretic switches the threshold required
to switch from one state to another depends on the expression
history, the state of the switch before the change in the inducer
concentration. Hysteresis is an important phenomenon, for
example in the lactose utilization operon of E. coli (Ozbudak
et al., 2004) or in ensuring unidirectional cell-cycle progression
in eukaryotic cells (Sha et al., 2003). Hysteretic switches make
gene expression more robust and noise resistant because the
expression state remains unchanged following small fluctuations
in inducer levels and only switches in response to significant
inducer concentrations changes.logy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 289
Chemistry & Biology
ReviewA
C
E F
D
B
HIF-1α
Figure 1. Synthetic gene networks in mammalian cells
(A) Synthetic transcription cascade. The (TET)-responsive promoter PTET triggers expression of the TET- and macrolide-dependent transactivators tTA and ET1.
tTA activates PTET in a positive feedback loop while ET1 induces expression of the streptogramin-dependent transactivator PIT under the control of the macro-
lide-responsive promoter PETR. PIT finally triggers production of the output gene SEAP (human placental secreted alkaline phosphatase) by binding and activating
PPIR. The transcription cascade can be interrupted by specifically inactivating tTA, ET1, or PIT by the addition of TET, erythromycin (EM) or pristinamycin I (PI),
respectively, which results in up to four discrete SEAP expression levels.
(B) Semi-synthetic transcription cascade. Under normoxia (NOX), the hypoxia-inducible factor 1a (HIF-1a) is primed for degradation by the proteasome (P). Under
hypoxia (HOX), HIF-1a translocates into the nucleus and binds to hypoxia-responsive element (HRE) triggering activation of the minimal simian virus 40 promoter
(PSV40min) thereby controlling expression of PIT. PIT induces production of tTA by binding and activating PPIR. tTA controls expression of the output gene SAMY
(Bacillus stearothermophilus-derived secreted a-amylase) via its cognate promoter PTET. The semi-synthetic transcription cascade is interrupted under normoxia
or by the addition of PI and TET for inactivating HIF-1a, PIT, and tTA, respectively, which results in up to six discrete SAMY expression levels.
(C) Coupled transcription-translation cascades providing improved regulation performance and tightness. In the absence of EM, E-KRAB represses expression
of a small interfering RNA (siRNAGFP) specific for a GFP-derived sequence tag (TAG), whereas triggers degradation of SEAP-encoding mRNA harboring the TAG
sequence. SEAP expression is activated by tTA in the absence of TET. Therefore, SEAP is fully expressed in the absence of regulating antibiotics, while addition of
both, TET and EM represses SEAP below the detection limit. Addition of only one antibiotic results in leaky expression.
(D) One-input-triggered transcription-translation cascade that improves transgene induction characteristics. In the absence of IPTG, LacI represses production
of the TET repressor TetR and the gene of interest (GOI). In addition, expression of a short hairpin RNA (shRNA), which is specific for a TAG sequence contained in290 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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synthetic hysteretic switches in mammalian cells (Kramer and
Fussenegger, 2005; May et al., 2008): (i) (Kramer and Fusseneg-
ger, 2005) put tTA under the control of a novel hybrid promoter,
which enabled dual TET- and EM-responsive expression. This
configuration created a positive feedback loop that rapidly
increases tTA expression along with cocistronically encoded
SEAP (Figure 1E). In addition, the positive feedback loop can
be interrupted by E-KRAB, which, in the absence of EM, binds
to the E-specific operator (ETR) operator contained in the hybrid
promoter and overrides tTA-based promoter activation. With
increasing EM concentrations, SEAP expression increased, de-
pending on the dose, until a plateau was reached. When the EM
concentrations were reduced further, SEAP levels decreased,
but the decrease occurred at significantly lower EM concentra-
tions than required for triggering the previous activation, thereby
demonstrating hysteretic behavior (Kramer and Fussenegger,
2005). (ii) In a subsequent approach, May and coworkers (May
et al., 2008) reduced the complexity of the first-generation
hysteretic switch by cocistronically expressing the reverse tetra-
cycline-dependent transactivator (rtTA) and enhanced green
fluorescent protein (eGFP) in an autoregulated manner (Fig-
ure 1F). Administration of the TET analog doxycycline (DOX) trig-
gers binding of rtTA to its promoter PTET, thereby further
increasing the expression of rtTA and of cocistronically encoded
eGFP. Fluorescence-activated cell sorting analysis of mamma-
lian cells treated with increasing DOX concentrations revealed
bimodal eGFP expression: cells are either highly fluorescent or
lack any fluorescence, but no intermediate expression levels
were detected that would be expected for classic transcription
control devoid of any positive feedback loop (Rossi et al.,
2000). This bimodal pattern, which is in accordance with
a stochastic model, results in stable and uniform levels of
expression across the entire cell population, and hardly any
clonal variation was observed. The hysteretic characteristics of
this system were evaluated by first increasing DOX concentra-
tions until all the cells exhibited eGFP fluorescence, followed
by a gradual decrease in DOX, resulting in a decrease in the
number of fluorescent cells. This decrease was observed at
DOX concentrations that were significantly lower than required
to yield comparable fluorescent fractions when ramping up
DOX (Figure 1F, May et al., 2008).
Synthetic Gene Networks: Performing Basic
Computational Functions
Boolean algebra, a logical calculus of truth values, is at the basis
of all devices that process information. Therefore, genetic
circuits, which can be designed to perform logical operations
of conjunction and disjunction, represent the basic buildingChemistry & Bioblocks for cell-based assemblies that could be expected to
execute basic computational functions.
Boolean NAND Gate
Boolean operations have been realized in a pilot study in
mammalian cells by Kramer et al. (2004a), in which transcrip-
tional control systems were interconnected to operate as NOT,
IF, OR, NAND, and NOR gates. For example, the NAND (NOT
AND, Figure 2A) gate consisted of ET1, which, in the absence
of EM, binds and activates PETR, resulting in the expression of
PIT. In the absence of the streptogramin antibiotic pristinamycin
I (PI), PIT binds and activates PPIR, thus triggering the expression
of the output gene SEAP. Only in the absence of both antibiotics
(EM = 0 AND PI = 0) is SEAP expression active (SEAP = 1); in all
other configurations SEAP is inactive (SEAP = 0), reflecting the
characteristics of the NAND gate.
Boolean AND Gate
Although the first BioLogic gates (Kramer et al., 2004a) relied on
transcriptional control, a study by Rinaudo et al. (2007)
described a universal siRNA-based logic evaluator, which oper-
ates in mammalian cells. In this configuration, siRNAs are used
as input signals to trigger destruction of specific target mRNAs
tagged with siRNA-specific sequence motifs (TAGs). Due to
the availability of multiple siRNAs and their cognate targets,
multiple inputs are possible and enable complex Boolean
operations such as (A AND B AND C) OR (D AND E). For the
AND gate (Figure 2B), administration of two different input
siRNAs (siRNA1 = 1 AND siRNA2 = 1) trigger destruction of two
targeted mRNAs harboring respective target sequences (TAG1
and TAG2). mRNA destruction prevents translation of coen-
coded LacI, thereby inducing de-repression of the PCAG
promoter fused to LacI-specific lacO operator sites, finally
resulting in monomeric red-fluorescent protein (dsRed) expres-
sion (dsRed = 1). Administration of only one (siRNA1 = 1 XOR
siRNA2 = 1) or no (siRNA1 = 0 AND siRNA2 = 0) input siRNA
results in LacI production and subsequent silencing of dsRed
(dsRed = 0) (Figure 2B).
An Epigenetic Memory Device
A fundamental characteristic of all data processing devices is the
capacity to store information. In order to emulate data storage in
a biological system as the basis of potential biocomputing
devices, a mammalian memory module was developed with the
storage capacity of 1 bit (Kramer et al., 2004b). This bistable
toggle switch consists of two promoters driving expression of
two different transsilencers that mutually repress these
promoters (Figure 2C). The first promoter PSV40(1) triggers
expression of SEAP and pristinamycin-inducible protein (PIP)-
KRAB,which, in the absenceof PI, binds to thePIP-specific oper-
ator (PIR) operator 30 of the second promoter (PSV40[2]), thereby
repressing PSV40(2). In the presence of PI, PIP-KRAB is released
from PIR and PSV40(2) triggers transcription of E-KRAB, which, inGOI transcripts, reduces GOI expression even further based on a RNA interference-based mechanism eliminating tagged GOI transcripts. In the presence of
IPTG, GOI expression is de-repressed and shRNA production is repressed by TetR, resulting in an increase in the activation of GOI expression by more than
100. The system enables dose-dependent expression of eGFP or induction of apoptosis by regulated expression of Bax.
(E) Hysteretic gene switch based on a transcription cascade. Expression of SEAP and the TET-dependent transactivator tTA is activated in a positive feedback
loop, where tTA triggers activation of the minimal promoter PhCMVmin. The positive feedback loop is interrupted by the binding of the repressor
E-KRAB to its operator ETR in the absence of EM. Hysteresis is observed when the EM concentration in the medium is gradually increased and then decreased.
(F) Bimodal and hysteretic gene switch based on a positive feedback loop. In the presence of doxycycline (DOX) PTET is activated in a positive feedback loop by the
reverse TET-dependent transactivator (rtTA). eGFP encoded on the same cistron is co-expressed with rtTA. With increasing DOX concentrations, the number of
fluorescent cells increases. When the DOX concentration is first increased and then decreased, hysteretic switching behavior of eGFP expression is observed.logy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 291
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Figure 2. Synthetic gene networks
performing basic computational functions
(A) Boolean algebra in mammalian cells. NAND gate
based on a transcriptional cascade. In the absence
of erythromycin (EM = 0), ET1 activates its promoter
PETR, driving expression of PIT, which activates its
cognate promoter PPIR in the absence of pristinamy-
cin I (PI = 0). Only in the absence of both antibiotics
(EM = 0 AND PI = 0) SEAP expression is induced
(SEAP = 1). In all other configurations, SEAP expres-
sion is repressed (SEAP = 0).
(B) AND gate based on modulation of posttranscrip-
tional expression. Addition of siRNA triggers destruc-
tion of its target mRNA harboring a specific comple-
mentary TAG sequence. mRNA decay prevents LacI
translation, thereby leading to de-repression of
PCAG and expression of the reporter dsRed. Only in
the presence of both siRNAs (siRNA1 = 1 AND
siRNA2 = 1) is dsRed expression active (dsRed = 1).
(C) Bi-stable memory. The bi-stable memory circuit
consists of two promoters, each driving expression
of a repressor to silence the other one. PIP-KRAB
binding to PIR silences the adjacent promoter
PSV40 in the absence of PI, whereas E-KRAB binding
to ETR silences the upstream promoter in the
absence of EM. The reporter SEAP is cocistronically
expressed with E-KRAB via the internal ribosome
entry site (IRES). Once one of the promoters has
been activated by the addition of the respective anti-
biotic, the expression state is maintained, even after
removal of the regulating drug (without antibiotics).
(D) Time-delay and band-detection circuit. Addition
of biotin triggers BirA-catalyzed covalent biotinyla-
tion of the herpes simplex virus protein 16 (VP16)
transactivation domain fused to the avitag biotinyla-
tion signal (AT). Biotinylated VP16 binds to streptavi-
din (SA) fused to the TET repressor TetR, which
binds to its cognate promoter PTET and results in
VP16-activated transcription of the reporter SEAP.
Time-delay circuit: A short pulse of biotin triggers
formation of biotinylated VP16, which accumulates
in the cell. Therefore, even after removal of
exogenous biotin, SEAP expression is sustained
(time-delay function) until biotinylated VP16 has
been degraded by the proteasome. Addition of
TET (+ TET) overrides the time-delay switch by
dissociating TetR from PTET. Band-detection func-
tion: Addition of increasing concentrations of biotin
to the circuit first correlates with increasing SEAP
expression due to the increase in biotinylated
VP16. A further increase in the biotin concentration
in themedium results in a dose-dependent decrease
in SEAP production since binding of biotinylated
VP16 to TetR-Streptavidin is competitively inhibited
by free biotin.292 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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represses this promoter. Administration of EM releases E-
KRAB from ETR, which results in derepression of PSV40(1) and
coordinated expression of PIP-KRAB and SEAP (Figure 2C). As
validated in transgenic mammalian cells and in mice for up to 3
weeks, this epigenetic toggle switch maintained and inherited
the SEAP expression status unless SEAP expression switches
were induced by addition of either PI (SEAP repression) or EM
(SEAP induction) (Kramer et al., 2004b). The dynamic range of
this first-generation mammalian epigenetic memory device was
significantly expanded by engineering intronically encoded
shRNAs into the transsilencers, which eliminated leaky tran-
scripts, bypassing from transsilencer-mediated transcription
shut down, via siRNA interference (Greber et al., 2008).
Synthetic Time-Delay and Band-Detection Circuits
Genetic circuitries, exhibiting time-delayed expression kinetics,
were shown to modulate nuclear factor kappa B activation,
tomanagequorum-sensing crosstalk and to control the circadian
clock (Weber et al., 2007c). In order to rationally design such
time-delayed expression circuits, vitamin H (biotin) was applied
to act as the signaling molecule (Weber et al., 2007c, Figure 2D).
In the presence of regulation-effective concentrations of biotin
constitutive expression of BirA mediates biotinylation of a syn-
thetic peptide tag (avitag, AT). Biotinylation of an avitag-VP16
fusion protein enables heterodimerization with a streptavidin
(SA)-tagged TetR that leads to reconstitution of a synthetic
TET-dependent transcription factor (TetR-SA-biotin-AT-VP16),
which induces expression from TET-responsive promoters
(PTET, Weber et al., 2007b). Time-delayed transgene expression
is observed when applying a short biotin pulse to the system,
thus triggering the accumulation of biotinylated VP16, which
persists in the cell and triggers SEAP expression even after
removal of biotin from the culture medium. The duration of
time-delayed gene expression is, therefore, determined by the
amount of biotinylated VP16 at the time of biotin removal and
by the degradation rate of AT-VP16, which can be modified by
fusion to proteasome-targeting PEST sequences. A complemen-
tary study (Weber et al., 2007b) showed that such time-delayed
gene expression can act as a filter to eliminate noise originating
from inducer fluctuations and provide rather uniform expression
kinetics.
Besides time-delayed expression kinetics, it was shown that
the same biotin-triggered circuit acts as a band-detection
network, responding only to a specific range of biotin concen-
trations. Gradual increase of biotin concentrations triggers
dose-dependent SEAP production until a plateau is reached,
indicating that at least one component of the signaling network
had become limiting; the PTET promoter was probably satu-
rated with bound synthetic transcriptions factors. As the biotin
concentration continues to increase, free biotin competes with
biotinylated VP16 for the SA binding sites (TetR-SA-biotin,
biotin-AT-VP16), which produces a transactivation-incompe-
tent TetR-SA-biotin fusion protein and leads to graded deacti-
vation of the target promoter (Figure 2D). Such band-detection
devices play crucial roles in the differentiation of the developing
embryo, where they translate the local concentration of
a gradient-forming signaling molecule into a threshold-based
steady activation or repression of differentiation-determining
genes.Chemistry & BioFrom Individual Cells to Interconnected Multicellular
Assemblies and Synthetic Ecosystems
All the above-mentioned genetic networks operatedwithin single
mammalian cells and required the stable transfection of up to six
expression cassettes, which is technically challenging and time-
consuming (Weber et al., 2007c). The next generation ofmamma-
lian cell-based synthetic gene networks will rely on the design
principle of electronic devices, whereby specialized integrated
circuits (microchips), which fulfill basic computational functions
(memory, logic functions, i/o interface), are interconnected to
form higher-order computational units that process signals not
only inside individual cells but also within and across cell popula-
tions of the sameor different species aswell as in tissues, organs,
and entire organisms. In order to establish intercellular crosstalk
among specialized mammalian cells, cell-to-cell communication
channels must be designed to coordinate and orchestrate the
overall response of the multicellular assemblies.
Cell-to-Cell Communication: Molecular Cell Phones
Basic principles of synthetic cell-cell communication networks
were established and developed first in bacteria (Bulter et al.,
2004) and then in yeast (Chen and Weiss, 2005). The first
synthetic mammalian communication device entirely assem-
bled from genetic parts was recently shown to manage informa-
tion transfer from a sender to a receiver cell in a contact-free
manner (we coined the term ‘‘molecular cell phone’’ for a cell-
to-cell communication device, Figure 3A, Weber et al., 2007a).
Such molecular ‘‘wireless’’ broadcasting included a sender
cell, engineered for constitutive or inducible expression of
a liver-derived alcohol dehydrogenase to convert traces
(& range) of spiked ethanol into acetaldehyde, which, having
a boiling point of 21C, diffuses via the gas or liquid phase to
the receiver cells (Weber et al., 2007a). The receiver cells
were engineered for an acetaldehyde-inducible expression
unit consisting of the Aspergillus nidulans-derived transcription
factor AlcR that activates the chimeric target promoter PAIR in
the presence of acetaldehyde (Weber et al., 2004). Considering
the acetaldehyde production kinetics and its transfer from the
sender to the receiver cells according to Fick’s law of diffusion,
this molecular cell phone can be used to design distance and
cell-density-controlled expression scenarios. In order to eval-
uate dependence on distance, culture wells containing the
receiver cells were placed at gradually increasing distances to
the culture wells harboring the sender cells, resulting in a gradual
decrease in SEAP production and demonstrating that this
system translates the spatial configuration of two cell popula-
tions into a graded protein production profile (Figure 3A, inset
i; Weber et al., 2007a). It could also be demonstrated that the
cell-to-cell communication system enables cell-density-
controlled induction of SEAP expression; high numbers of
sender cells triggered an immediate onset of SEAP production,
whereas decreasing populations of sender cells correlated with
a longer time delay until SEAP expression was initiated (Fig-
ure 3A, inset ii; Weber et al., 2007a). Such cell-density-depen-
dent induction of transgene expression can be used to design
autonomously operating bioprocesses, where expression of
product genes is induced automatically once an optimum cell
density has been reached. An increasing size of the sender
cell population correlated with increasing levels of SEAP
production, demonstrating the potential use of thislogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 293
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Reviewcommunication system in mammalian cell-based quorum-
sensing (biopharmaceutical manufacturing) configurations
(Figure 3A, inset iii; Weber et al., 2007a). This acetaldehyde-
based communication system was also shown to function in
multistep signal processing cascades and was successfully
assembled into the first synthetic hormone system in mice in
which sender cell inserts were communicating across the living
animal to instruct remote receiver cell implants to produce
a human glycoprotein in the bloodstream of treated mice
(Weber et al., 2007a). More recently, mammalian system was
described in which sender cells were engineered to produce ni-
tric oxide as diffusible messenger that triggers c-fos promoter
and reporter gene expression in engineered receiver cells
(Wang et al., 2008). Here, quorum-sensing like behavior was
produced by integrating sender module into receiver cells under
negative feedback control.
Synthetic Ecosystems
The capacity to connect several cells or organisms with each
other by molecular communication mechanisms enables the
design of synthetic ecosystems to emulate and analyze the
coexistence and interactions of different species (Weber et al.,
2007a). For example, a synthetic predator-prey ecosystem
A
B
Figure 3. Cell-to-cell communication and
synthetic ecosystems
(A) Cell-to-cell communication. The sender cell is
genetically engineered to express alcohol dehy-
drogenase (ADH), resulting in the conversion of
ethanol to acetaldehyde, which, with a boiling point
of 21C, diffuses through the gas or liquid phase to
the receiver cells. The receiver cell harbors the
Aspergillus nidulans-derived transcription factor
AlcR that activates its cognate promoter PAIR in
the presence of acetaldehyde, resulting in the
expression of the reporter SEAP. (i) Dependence
on distance: SEAP expression decreases with
increasing distance between the sender and
receiver cultures. (ii) Dependence on time: Early
onset of SEAP production in the receiver cells
correlates with a high number of sender cells,
whereas a lower number of sender cells correlates
with a longer delay before to the induction of gene
expression. (iii) Dependence on concentration:
After a fixed period, the level of SEAP expression
reflects the population density of the sender cells.
(B) Synthetic predator-prey interactions. Chinese
hamster ovary (CHO) cells were genetically engi-
neered to express b-lactamase fused to an IgG-
derivedsecretionsignal (sBla).Secretedb-lactamase
triggers degradation of ampicillin in the medium,
thereby enabling the survival of E. coli cells, which
grow, consume nutrients, and produce toxic by-
products, which in turn reduces the viability of the
CHO cells. When the whole system is semi continu-
ously supplied with fresh medium containing ampi-
cillin, the population densities of the parasite (E. coli)
and the host (CHO) oscillated with shifted phases.
with oscillating population dynamics was
recently described. It consists of E. coli
as the predator and of Chinese hamster
ovary (CHO-K1) cells, engineered for
constitutive production of a secreted b-
lactamase, as the prey. Both species
were cocultivated in standard culture
dish equipped for semicontinuous supply of fresh medium and
ampicillin. Upon start of the predator-prey ecosystem, E. coli
growth is restricted by ampicillin and CHO cells proliferate,
thereby secreting b-lactamase, which lowers ampicillin levels.
As ampicillin concentrations decrease, E. coli recovers and
resumes growth, which compromises viability of the mammalian
cells due to bacteria-mediated nutrient depletion. Because
a declining CHO cell population produces lower amounts of
secreted b-lactamase, ampicillin levels continue to increase,
which decimates E. coli and allows recovery of the mammalian
cell population to initiate another cycle of oscillating population
dynamics (Figure 3B).
This synthetic prokaryote-eukaryote ecosystem could serve
as a model for the design of synthetic host-pathogen ecosys-
tems that characterize disease dynamics with unmatched preci-
sion and help devise or refine therapeutic strategies accordingly.
Future Directions of Mammalian Synthetic Biology
Mammalian cell-based synthetic biology is expected to develop
into two major directions: (i) the knowledge-producing ‘‘basic
synthetic biology’’ enabling fundamental scientific discoveries
and providing insight into operation dynamics of complex294 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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(ii) ‘‘translational synthetic biology,’’ which leads from evidence-
based ‘‘basic synthetic biology’’ to sustainable solutions for
pertinent public health problems. Both synthetic biology disci-
plines will gather tremendous momentum by integrating recent
advances in ‘‘enabling technologies’’ such as large-scale DNA
synthesis (Gibson et al., 2008), (single-cell) analytics (Cordey
et al., 2008), nanotechnology (Maerkl and Quake, 2007), and
materials science (Lutolf and Hubbell, 2005), as well as
‘‘enabling sciences’’ including systems biology and bioinfor-
matics, which quantitatively capture the dynamics of biological
phenomena at a systems scale (Aebersold and Mann, 2003).
Future developments in ‘‘basic synthetic biology’’ will largely
be dependent on standardized orthogonal mammalian cell-
compatible biologic devices developed de novo or being adap-
ted for use inmammalian cells following blueprints established in
prokaryotes. Such devices might include novel input interfaces
triggered by light (Levskaya et al., 2005) or by electricity to
enable electrogenetic interfaces and harness advances in elec-
tronics for control of living systems. Mammalian versions of
complex synthetic gene networks showing oscillating expres-
sion dynamics such as described for E. coli (Elowitz and Leibler,
2000; Stricker et al., 2008) have just been developed (Tigges
et al., 2009). Rewiring of intracellular signaling pathways
enabling synthetic connection of any receptor-mediated input
with any desired target gene such as recently established in
yeast still lacks similar implementation in mammalian cells (Yeh
et al., 2007). Also, mammalian homologs of complex two-way
communication at multicellular scale such as recently estab-
lished in E. coli by engineering of orthogonal acylhomoserine-
lactone-based circuits (Balagadde et al., 2008) could enable
multichannel intercell signaling to coordinate cell growth and
differentiation of organ-like cellular assemblies or might be
used to design prosthetic hormone signaling for future therapies.
Mammalian cell-based ‘‘translational synthetic biology’’ is
expected to foster advances in drug discovery, gene therapy,
tissue engineering, and biopharmaceutical manufacturing. For
drug discovery, the synthetic reconstruction of healthy or patho-
logic signaling cascades in an orthogonal host could be an ideal
approach to elucidate signal processing dynamics as exempli-
fied at the reconstruction of the B cell antigen receptor signal
transduction pathway in insect cells (Wossning and Reth,
2004). For gene therapy, semisynthetic gene networks are
expected to emerge that enable engineered cells to autono-
mously sense a pathologic state (e.g., abnormal concentrations
of glucose) and coordinate a corresponding therapeutic action
(e.g., secretion of insulin) in a self-sufficient manner. For tissue
engineering, reprogramming of differentiation pathways to
coordinate (stem) cell fate in artificial tissues using synthetic
signaling and transcription networks could become an essential
technology for the treatment of tissue-specific diseases.
For biopharmaceutical manufacturing, mammalian-cell-based
translational synthetic biology might become fundamental for
targeted manipulation of product quality (Tomiya et al., 2003)
or expanding protein function by introduction of non-canonical
amino acids (Summerer et al., 2006).
Although mammalian cell-based translational synthetic
biology is unique in having a great potential to improve human
therapies in the not-so-distant future, applications of syntheticChemistry & Biobiology are already in use today, for example for pest control.
The Mediterranean fruit fly (Ceratitis capitata) is an insect pest
that is inflicting heavy economic damage on agriculture. Fu
et al. (2007) designed a synthetic circuit for autoregulated
expression of tTA, which was engineered for female-specific
splicing and could only accumulate to toxic levels in female flies
living in a TET-free environment. Production and release of trans-
genic male flies will compete with wild-type flies for mating with
female flies, thereby infiltrating the fly population with the
synthetic circuitry that will rapidly disseminate within the wild-
type male population, whereas the female population is
constantly decreasing until the fly will be extinct (Fu et al., 2007).
In conclusion, synthetic biology is rapidly developing from
a loose network of scientists with different education and
scientific background into an interdisciplinary global community
convinced that the engineering of biology—in essence the
rational design of biological systems in a systematic manner—
might offer solutions to major societal and health-associated
challenges of the 21st century.
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